Evidence map

ArticleEMBO molecular medicine2025

FABP4 as a therapeutic host target controlling SARS-CoV-2 infection.

Hatoon Baazim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39843629